Christopher Pittenger
Program Director/Contact, Integrated Mentored Patient-Oriented Research Training (IMPORT) in Psychiatry · Yale University
Credentials: · · · · · · · ·
History
Present/Contact, Integrated Mentored Patient-Oriented Research Training (IMPORT) in Psychiatry · Yale University
PresentNeuroscience Research Training Program, Yale Department of Psychiatry · Yale University
PresentYale Program for Psychedelic Science · Yale University
2003–2007
Until 2007- 2003
Columbia College of Physicians and Surgeons


1994
1994
Research
Analysis of shared heritability in common disorders of the brain
Science · 2018 · 1,466 citations
Stress, depression, and neuroplasticity: a convergence of mechanisms
Review · Neuropsychopharmacology · 2008 · First of 2 authors · 1,334 citations
Meta-analysis of the symptom structure of obsessive-compulsive disorder
Systematic review or meta-analysis · American Journal of Psychiatry · 2008 · 421 citations
- MB
37 papers · 10 as a resident
- BK
32 papers · 5 as a resident

21 papers

20 papers
- JL
16 papers · 10 as a resident
- TA
13 papers

11 papers

11 papers
Grants
- 1996–2029
Clinical Neuroscience Research Training Program in Psychiatry
National Institute of Mental Health · T32
Contact PI · $1.8M · Yale University
- 2024–2029
IMPACT-MH: Clinical and Behavioral Fingerprints of Psychopathology
National Institute of Mental Health · U01
Contact PI · $20.6M · Yale University
- 2026–2028
DECIPHER-OCD: Comprehensive Characterization of Brain Structure in OCD
National Institute of Mental Health · R21
Contact PI · $460.6K · Yale University
- 2005–2028
Integrated Mentored Patient-Oriented Research Training (IMPORT) in Psychiatry
National Institute of Mental Health · R25
Contact PI · $1.5M · Yale University
Clinical trials
- 2019–2027
Brain Network Changes Accompanying and Predicting Responses to Pharmacotherapy in OCD
Principal investigator · Recruiting · Phase 1, Phase 2
Yale University
- 2007–2010
N-Acetylcysteine in Adjunct to DBT for the Treatment of Self-Injurious Behavior in BPD
Principal investigator · Terminated · Phase 2
Yale University
- 2006–2015
Riluzole Augmentation in Treatment-refractory Obsessive-compulsive Disorder
Principal investigator · Completed · Phase 2
Yale University
- 2006–2011
N-Acetylcysteine Augmentation in Treatment-Refractory Obsessive-Compulsive Disorder
Principal investigator · Terminated · Phase 2
Yale University

